Gestational Trophoblastic Disease

Alampady K.P. Shanbhogue; Neeraj Lalwani; Christine O. Menias

doi:10.1016/j.rcl.2013.07.011

Gestational Trophoblastic Disease

Alampady K.P. Shanbhogue, Neeraj Lalwani, Christine O. Menias

Radiology

Research output: Contribution to journal › Review article

17 Scopus citations

Abstract

Imaging plays a crucial role in diagnosis and management of gestational trophoblastic disease. Ultrasonography is the initial investigation of choice for the diagnosis. Pelvic magnetic resonance (MR) imaging is used as a problem-solving tool for assessment of degree of local invasion. Chest radiography is the recommended initial radiographic staging modality, and chest computed tomography is performed if the radiograph is negative. ¹⁸F-Fluorodeoxyglucose positron emission tomography has been shown to be useful in assessing the active or viable sites of metastases, thereby determining the need for tumor resectability in chemoresistant disease.

Original language	English (US)
Pages (from-to)	1023-1034
Number of pages	12
Journal	Radiologic Clinics of North America
Volume	51
Issue number	6
DOIs	https://doi.org/10.1016/j.rcl.2013.07.011
State	Published - Nov 1 2013

Fingerprint

Keywords

Choriocarcinoma
Hydatidiform mole
Magnetic resonance imaging

ASJC Scopus subject areas

Radiology Nuclear Medicine and imaging

Cite this

Shanbhogue, A. K. P., Lalwani, N., & Menias, C. O. (2013). Gestational Trophoblastic Disease. Radiologic Clinics of North America, 51(6), 1023-1034. https://doi.org/10.1016/j.rcl.2013.07.011

@article{f5be45729b084f8998e91800dced94d4,

title = "Gestational Trophoblastic Disease",

abstract = "Imaging plays a crucial role in diagnosis and management of gestational trophoblastic disease. Ultrasonography is the initial investigation of choice for the diagnosis. Pelvic magnetic resonance (MR) imaging is used as a problem-solving tool for assessment of degree of local invasion. Chest radiography is the recommended initial radiographic staging modality, and chest computed tomography is performed if the radiograph is negative. 18F-Fluorodeoxyglucose positron emission tomography has been shown to be useful in assessing the active or viable sites of metastases, thereby determining the need for tumor resectability in chemoresistant disease.",

keywords = "Choriocarcinoma, Hydatidiform mole, Magnetic resonance imaging",

author = "Shanbhogue, {Alampady K.P.} and Neeraj Lalwani and Menias, {Christine O.}",

year = "2013",

month = nov

day = "1",

doi = "10.1016/j.rcl.2013.07.011",

language = "English (US)",

volume = "51",

pages = "1023--1034",

journal = "Radiologic Clinics of North America",

issn = "0033-8389",

publisher = "W.B. Saunders Ltd",

number = "6",

}

TY - JOUR

T1 - Gestational Trophoblastic Disease

AU - Shanbhogue, Alampady K.P.

AU - Lalwani, Neeraj

AU - Menias, Christine O.

PY - 2013/11/1

Y1 - 2013/11/1

N2 - Imaging plays a crucial role in diagnosis and management of gestational trophoblastic disease. Ultrasonography is the initial investigation of choice for the diagnosis. Pelvic magnetic resonance (MR) imaging is used as a problem-solving tool for assessment of degree of local invasion. Chest radiography is the recommended initial radiographic staging modality, and chest computed tomography is performed if the radiograph is negative. 18F-Fluorodeoxyglucose positron emission tomography has been shown to be useful in assessing the active or viable sites of metastases, thereby determining the need for tumor resectability in chemoresistant disease.

AB - Imaging plays a crucial role in diagnosis and management of gestational trophoblastic disease. Ultrasonography is the initial investigation of choice for the diagnosis. Pelvic magnetic resonance (MR) imaging is used as a problem-solving tool for assessment of degree of local invasion. Chest radiography is the recommended initial radiographic staging modality, and chest computed tomography is performed if the radiograph is negative. 18F-Fluorodeoxyglucose positron emission tomography has been shown to be useful in assessing the active or viable sites of metastases, thereby determining the need for tumor resectability in chemoresistant disease.

KW - Choriocarcinoma

KW - Hydatidiform mole

KW - Magnetic resonance imaging

UR - http://www.scopus.com/inward/record.url?scp=84887196817&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84887196817&partnerID=8YFLogxK

U2 - 10.1016/j.rcl.2013.07.011

DO - 10.1016/j.rcl.2013.07.011

M3 - Review article

C2 - 24210442

AN - SCOPUS:84887196817

VL - 51

SP - 1023

EP - 1034

JO - Radiologic Clinics of North America

JF - Radiologic Clinics of North America

SN - 0033-8389

IS - 6

ER -

Access to Document

10.1016/j.rcl.2013.07.011